参考文选:
[1] Hollister LE, Chemical Psychoses. Charles Thomas Press, Springfield, IL, 1968: 17-18.
[2] Ott J, Hallucinogen Plants of North America, , Wingbow Press, Berkley, CA, 1976: 83-112.
[3] Wasson RG, Ingalls DH, The soma of the Rig Veda: what was it? J Am Orient Soc 1971, 91: 169-187.
[4] Nichols DE, Hallucinogens Pharmacol Ther, 2004, 101:131-181.
[5] 王纪潮,昏迷药与不死药──战国秦汉时期中国社会宗教意识的转向,宗教与医疗学术研讨会暨亚洲医学史学会第二次年会论文集,中国台北,2004。
[6] Hofmann A, LSD - My Problem Child. McGraw-Hill, 1980.
[7] Shulgin A, Shulgin A, PiHKAL: a chemical love story. Transform. Press, Berkley, CA, 1991.
[8] Shulgin A, Shulgin A, TiHKAL: the continuation. Transform. Press, Berkley, CA, 1997.
[9] Glennon RA, Classical Hallucinogens: an introductory overview. NIDA Res Monogr. 1994;146:4-32.
[10] Cerletti A, Rothlin E, Role of 5-hydroxytryptamine in mental disease and its antagonism to lysergic acid derivatives. Nature, 1955, 176:785-786.2
[11] Jacobs BL, Trulson ME, Stern WC, An animal behavior. model for studying the actions of LSD and related hallucinogens. Science. 1976 194:741-743.
[12] Young R, Glennon RA, Discriminative stimulus properties of amphetamine and structurally related phenalkylamines. Med Res Rev. 1986, 6(1):99-130.
[13] Winter JC, The stimulus effects of serotonergic hallucinogens in animals. NIDA Res Monogr. 1994;146:157-182.
[14] Vollenweider FX, Vollenweider-Scharfetter C, Maguire P, et al., Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport, 1998, 9: 3897-3902.
[15] Strassman RJ, Human psychopharmacology of N,N-dimethyltryptamine. Behav Brain Res 1996;73:121-124.
[16] Grof S, Realms of the human unconscious. Observations from LSD research, Viking Press, New York, 1975.
[17] Hollister LE, Effects of hallucinogens in humans. In Jacobs BL (Ed.) Hallucinogens: neurochemical,behavioral, and clinical perspectives. Raven Press, New York, 1984: 19-33.
[18] 2004 National Survey on Drug Use and Health: detailed table. www.samhsa.gov
[19] Mullis K,Dancing naked in the mind field. Random House,New York, 2000.
[20] Halpern JH, Pope HG Jr, Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry, 2001, 158: 481-0483.
[21] Grinspoon L, Bakalar JB, Psychedelic drugs reconsidered.Basic Book Inc.Publishers, New York, 1979.
[22] Griffiths RR, Richards WA, McCann U, Jesse R, Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl). 2006, 187:268-283.
[23] www.lsd.info, LSD: problem child and woder drug, international symposium on the occasion of the 100th birthday of Albert Hofmann, Basel, Switzerland.
[24] Colpaert FC, Discovering risperidone: the LSD model of psychopathology.
[25]国家药物滥用监测中心,2003药物滥用监测报告书,中国药物依赖性研究所,2004。